CAS 202825-45-4

(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate

CAS : 202825-45-4

Formule : C₁₈H₂₃FN₂O₅S

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 398.4490

Ref: IN-DA0028G2

Ralfinamide mesylate

CAS : 202825-45-4

Ralfinamide mesylate

Degré de pureté : ≥98%

Masse moléculaire : 398.45g/mol

Ref: 54-BUP07125

Ralfinamide Mesylate

CAS : 202825-45-4

Ralfinamide Mesylate

Degré de pureté : ≥98%

Masse moléculaire : 398.45g/mol

Ref: 54-PC108889

Ralfinamide mesylate

CAS : 202825-45-4

Ralfinamide mesylate (FCE-26742A (mesylate)) is an orally available Na+ channel blocker.

Formule : C₁₈H₂₃FN₂O₅S

Degré de pureté : 99.83%

Couleur et forme : Solid

Masse moléculaire : 398.45

Ref: TM-T7547

Ralfinamide Mesylate

CAS : 202825-45-4

Applications Ralfinamide mesylate is a mixed sodium and N-type calcium channel protein inhibitor. Inhibitory activity of Ralfinamide mesylate is voltage dependent, with higher potency towards inactivated channels. Ralfinamide mesylate is useful in preventing, alleviating and curing a wide range of pathologies, including pain, migraine, peripheral diseases, cardiovascular diseases, inflammatory processes affecting all body systems, disorders affecting skin and related tissues, disorders of the respiratory system, disorders of the immune and endocrinol. systems, gastrointestinal, urogenital, metabolic and seizure disorders.
References Bayes, M., et al.: Methods. Find. Exp. Clin. Pharmacol., 27, 411 (2005); Pevarello, P., et al.: J. Med. Chem., 41, 579 (1998); Bauer, M., et al.: Pharmacol., 85, 297 (2010);

Formule : C₁₇H₁₉FN₂O₂·CH₄O₃S

Couleur et forme : White Solid

Masse moléculaire : 398.449

Ref: TR-R075000

(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate

CAS : 202825-45-4

Formule : C₁₈H₂₃FN₂O₅S

Degré de pureté : ≥98%(HPLC)

Masse moléculaire : 398.45

Ref: 10-F227571